Neurizon Therapeutics Statistics

Total Valuation

ASX:NUZ has a market cap or net worth of AUD 57.29 million. The enterprise value is 50.96 million.

Market Cap	57.29M
Enterprise Value	50.96M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:NUZ has 698.63 million shares outstanding. The number of shares has increased by 14.98% in one year.

Current Share Class	698.63M
Shares Outstanding	698.63M
Shares Change (YoY)	+14.98%
Shares Change (QoQ)	+4.68%
Owned by Insiders (%)	20.54%
Owned by Institutions (%)	n/a
Float	520.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.58
PB Ratio	6.91
P/TBV Ratio	6.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.43
EV / Sales	8.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.92

Financial Position

The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.20.

Current Ratio	2.18
Quick Ratio	1.98
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	-117.27

Financial Efficiency

Return on equity (ROE) is -147.09% and return on invested capital (ROIC) is -85.20%.

Return on Equity (ROE)	-147.09%
Return on Assets (ROA)	-60.21%
Return on Invested Capital (ROIC)	-85.20%
Return on Capital Employed (ROCE)	-179.21%
Weighted Average Cost of Capital (WACC)	11.10%
Revenue Per Employee	1.49M
Profits Per Employee	-3.71M
Employee Count	4
Asset Turnover	0.39
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.40% in the last 52 weeks. The beta is 1.27, so ASX:NUZ's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	-34.40%
50-Day Moving Average	0.09
200-Day Moving Average	0.13
Relative Strength Index (RSI)	36.44
Average Volume (20 Days)	560,007

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:NUZ had revenue of AUD 5.98 million and -14.85 million in losses. Loss per share was -0.03.

Revenue	5.98M
Gross Profit	5.98M
Operating Income	-14.87M
Pretax Income	-14.85M
Net Income	-14.85M
EBITDA	-14.87M
EBIT	-14.87M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 7.95 million in cash and 1.62 million in debt, giving a net cash position of 6.33 million or 0.01 per share.

Cash & Cash Equivalents	7.95M
Total Debt	1.62M
Net Cash	6.33M
Net Cash Per Share	0.01
Equity (Book Value)	8.29M
Book Value Per Share	0.02
Working Capital	8.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.45 million and capital expenditures -7,038, giving a free cash flow of -17.46 million.

Operating Cash Flow	-17.45M
Capital Expenditures	-7,038
Free Cash Flow	-17.46M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -248.65% and -248.37%.

Gross Margin	100.00%
Operating Margin	-248.65%
Pretax Margin	-248.37%
Profit Margin	-248.37%
EBITDA Margin	-248.65%
EBIT Margin	-248.65%
FCF Margin	n/a

Dividends & Yields

ASX:NUZ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.98%
Shareholder Yield	-14.98%
Earnings Yield	-25.92%
FCF Yield	-30.48%

Stock Splits

The last stock split was on October 30, 2015. It was a reverse split with a ratio of 0.05.

Last Split Date	Oct 30, 2015
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:NUZ has an Altman Z-Score of -3.91 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.91
Piotroski F-Score	1